Humana Inc vs Newmont Corporation — how do they compare? Humana Inc trades at $433.13 (market cap $46.49B), while Newmont Corporation trades at $118.48 (market cap $121.75B). The key difference: Newmont Corporation is far larger — about 2.6× Humana Inc's market cap, and Humana Inc pays the higher dividend (0.91%). Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Newmont Corporation for 58 Days on average.
| HUM | NEM | |
|---|---|---|
Market Cap | $46.49B | $121.75B |
Volume | 2,567,704 | 5,421,125 |
Sector | Health | Basic Materials |
52-Week High | $409.85 | $135.14 |
52-Week Low | $163.67 | $78.63 |
Typical Hold Time | 53 Days | 58 Days |
Enterprise Value | $53.84B | $118.34B |
Dividend Yield | 0.91% | 0.9% |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $441.74, up 11.41% over 24 hours, reflecting strong momentum. The stock shows bullish technical signals with support at $391 and resistance at $406. Fundamentally, revenue grew to $129.66B in 2025, though net income margin compressed to 0.88%. Recent news highlights a Barclays upgrade to a $515 price target and upcoming Q3 earnings on November 6, 2026.
The outlook is cautiously optimistic with a consensus price target of $457.05 implying modest upside. Risks include margin pressure from Medicare Advantage plan changes and potential regulatory scrutiny. Institutional activity is mixed, with Bank of America adding a position while some funds reduced stakes.
Newmont Corporation (NEM) trades at $113.54, down 2.45% over 24 hours, with technical indicators showing a bearish short-term trend. The company reported strong fundamentals, including record free cash flow of $5.3 billion in H1 2026 (Defense World, 2026-10-01) and consistent earnings beats in recent quarters. Revenue grew to $22.67 billion in 2025, with net income margin improving to 31.25%. Analyst sentiment remains positive, with a consensus price target of $136.83 and 76% buy ratings.
The outlook for NEM is supported by robust cash flow generation and operational improvements, but near-term price pressure exists from technical bearish signals and gold price volatility. Investment appeal lies in its valuation metrics, such as a P/E of 14.57, and shareholder returns via dividends. Key risks include sensitivity to gold prices and execution of growth projects. The stock offers value for long-term investors despite current market weakness.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →Newmont Corp is primarily a gold producer with operations and/or assets in the United States, Canada, Mexico, Dominican Republic, Peru, Suriname, Argentina, Chile, Australia, and Ghana. It is also engaged in the production of copper, silver, lead and zinc. The company's operations are organized in five geographic regions: North America, South America, Australia, Africa and Nevada.
Read more on NEM →